← Browse by Condition
Medical Condition

locally advanced pancreatic cancer with kras g12d mutation

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07438106 Phase 2
Recruiting

A Phase III Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer

Enrollment
30 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →